Therapeutic Effect of an Anti-Human Programmed Death-Ligand 1 (PD-L1) Nanobody on Polymicrobial Sepsis in Humanized Mice
Zhenzhen Zhao(Lanzhou University), Xiaoming Deng(Second Military Medical University), Jian Xie(Tongji University), Qian Li(Capital Medical University), Xiaolin Wang(University of Science and Technology of China), Liping Chen, Xiaoxiao Wang(Sichuan University), Jiafeng Wang(Zhejiang International Studies University)
Cited by 12
Related Papers
Acalabrutinib (ACP-196) in Relapsed Chronic Lymphocytic Leukemia
|New England Journal of Medicine|2015|890
Inhibition of neuronal ferroptosis protects hemorrhagic brain
|JCI Insight|2017|702
Serum miR-146a and miR-223 as potential new biomarkers for sepsis
|Biochemical and Biophysical Research Communications|2010|361